Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Account Payables: 2012-2025

Historic Change in Account Payables for CorMedix (CRMD) over the last 7 years, with Sep 2025 value amounting to $6.5 million.

  • CorMedix's Change in Account Payables rose 424.80% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 397.19%. This contributed to the annual value of -$2.6 million for FY2024, which is 223.20% down from last year.
  • CorMedix's Change in Account Payables amounted to $6.5 million in Q3 2025, which was up 67.41% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Change in Account Payables peaked at $6.5 million during Q3 2025, and registered a low of -$2.0 million during Q3 2024.
  • Moreover, its 3-year median value for Change in Account Payables was $294,655 (2024), whereas its average is $909,900.
  • In the last 5 years, CorMedix's Change in Account Payables plummeted by 92.35% in 2024 and then spiked by 648.76% in 2025.
  • Quarterly analysis of 4 years shows CorMedix's Change in Account Payables stood at $434,753 in 2022, then reached -$755,582 in 2023, then tumbled by 92.35% to $376,360 in 2024, then spiked by 424.80% to $6.5 million in 2025.
  • Its Change in Account Payables stands at $6.5 million for Q3 2025, versus $3.9 million for Q2 2025 and $212,950 for Q1 2025.